|Bid||69.27 x 1800|
|Ask||71.40 x 1800|
|Day's Range||71.61 - 73.44|
|52 Week Range||60.14 - 83.88|
|Beta (3Y Monthly)||1.03|
|PE Ratio (TTM)||23.64|
|Earnings Date||Feb 6, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||2.00 (2.78%)|
|1y Target Est||93.00|
Larry Merlo has learned a few things during nearly eight years as CEO of one of the nation's biggest drugstore chains — including that you shouldn't ever stop learning. CVS Health Corp. is polishing off a $69-billion acquisition of the health insurer Aetna. The company, which also manages pharmacy benefits, is focusing more on providing in-store health care services and telemedicine, as retailers face pressing competition for product sales from the online giant Amazon.com.
CVS Health CEO Larry Merlo wants customers to think about more than prescriptions and shampoo when they visit his company's drugstores. CVS has largely finished its $69 billion acquisition of the insurer Aetna, part of the company's broader effort to expand its health care offerings. Merlo spoke recently with The Associated Press.
CVS Health Corp (CVS.N) defended on Friday an agreement with the U.S. Justice Department which allowed it to purchase health insurer Aetna for $69 billion, a settlement that a federal judge is still assessing. The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc (WCG.N). Now, the Justice Department and companies have found themselves in the unusual position of defending their antitrust settlement to a skeptical federal judge.
The problem began in 1986 when doctors and health organizations began advocating for the use of opioids to treat chronic pain, according to the Mayo Clinic. From rural West Virginia to Chicago’s inner city, communities have been inundated with prescription pain killers and their illicit counterparts like heroin. As a result of our health care system’s overreliance on opioids, there are an estimated 2 million Americans who are dependent on opioids.
Goldman analyst Robert Jones said he doesn't think Walgreens' numerous partnerships with other companies will help offset declines in its core retail pharmacy business. He downgraded Walgreens to "sell" ...
Goldman analyst Robert Jones said he doesn't think Walgreens' numerous partnerships with other companies will help offset declines in its core retail pharmacy business. He downgraded Walgreens to "sell" from "hold" Friday.
SINGAPORE (AP) — Asian markets tumbled on Friday after China reported weaker-than-expected economic data, stirring up worries about the state of the world's second largest economy.
Amazon (AMZN) stock has fallen over 16% in the last three months as part of the larger market pullback driven by the likes of Apple (AAPL) and other giants. The company's days of 40% top-line growth might also be over. But let's dive into Amazon's overall business picture and outlook to see if investors should buy AMZN stock heading into 2019.
Stocks that moved substantially or traded heavily Thursday: CVS Health Corp., down $1.13 to $73.37 The New York Post reported that a judge might bar CVS from integrating its business with health insurer ...
The Dow Jones Industrial Average rose Thursday as Wall Street expressed optimism over U.S. and China trade talks. said Thursday it would invest $1 billion to build a new campus in Austin, Texas. Stocks traded mixed on Thursday, Dec. 13, as Wall Street monitored trade developments between the U.S. and China, the world's two largest economies.
Jason Moser’s pick for the contest is Teladoc Health (NASDAQ:TDOC). Thankfully, virtual healthcare provider Teladoc Health (NASDAQ:TDOC) is leveraging medical expertise to impact consumers around the world and offer them more options in a market which seems mired in red tape. While the concept of telehealth is still new to many, it is being seen more and more as an excellent option in many cases and the investments Teladoc is making in its business today could pay off big down the road as telehealth becomes a more meaningful part of the overall healthcare industry.
U.S. stock futures were mixed on Thursday, Dec. 13, and shares in Asia closed higher as trade tensions eased between the U.S. and China, the world's two largest economies. Wall Street finished higher on Wednesday, Dec. 12, as investors cheered progress in U.S.-China trade talks and after a report said China was planning a new program that promised greater access for foreign companies. The Wall Street Journal reported Wednesday that China was drafting a replacement for Made in China 2025 - President Xi's blueprint to make the country a leader in high-tech industries - which would play down China's bid to dominate manufacturing and be more open to participation by foreign companies.
Dividend growth stocks have obvious appeal. After all, dividend investing is based on buying and holding a stock for the payouts. Unlike traditional growth investing, where you depend on a stock increasing in value based on profits or sales trends, dividend investing focuses on the payouts above all else.
CVS Health (CVS) estimates a $750-million earning from near-term synergies with low- to mid-single digit addition in the second year after the closure of Aetna transaction.
CVS Health acquired health insurance giant Aetna for about $70 billion. CVS has bought other pharmacies to build its footrprint, as well as pharmacy benefit manager Caremark and walk-in health clinic MinuteClinic. It's buying a health insurer to prove it.
To start 2018, many on Wall Street were predicting a great year for stocks, as Donald Trump's tax plan was expected to produce elevated mergers and acquisitions activity. The deal activity has certainly been a part of the 2018 story, but the trend could slow down in 2019, said analysts from Goldman Sachs. Deal announcements are expected to increase 20% year over year in 2018, according to a note from Goldman that was released Tuesday.
The latest list of new buys by the best mutual funds shows a focus on large cap stocks like Berkshire, led by Warren Buffett, CVS, Starbucks and Adobe.